News archive

In a nationwide survey, more than 2,000 patients, caregivers, and clinicians told us what cancer care gets right, and where we can collaborate to improve. 

A year ago, we committed to investing $23 billion in America’s health over the next five years. Here’s a look at the impact we’ve made so far—plus a new initiative we’re launching in five cities to drive awareness and earlier detection of breast and prostate cancer. 

May is Stroke Awareness Month – a moment to pause and reflect on one of the leading causes of serious disability and death in the United States. Nearly 800,000 people in the US experience a stroke each year and every 40 seconds someone experiences one. Yet, despite how common stroke is, many people are still unaware of their risk – and what can be done to reduce it¹.

Findings from the Breast Health & Experience Index reveal many women diagnosed with breast cancer want earlier, more honest conversations about the possibility of recurrence to help them feel more informed and empowered. 

Today, 1 in 10 people in the United States have an autoimmune disease. Scientific innovations are opening pathways to help more patients. 

For Susan, having two heart attacks in the span of a year was a wake-up call. It led her to be tested for high lipoprotein (a), a hidden heart disease risk factor that approximately 1 in 5 Americans may have¹. 

If we look beyond the latest health trends, a healthy heart is the true key to more life in every year. Novartis US President Victor Bultó explains why preventing cardiovascular disease is the longevity breakthrough that matters.

In this interview, Des shares his perspective on why it is important we work to better support healthcare practitioners who help treat our patients, and why real innovation resides in people as much as it resides in products.

How a Novartis data platform is turning real-world evidence into actionable insights for urologists and oncologists.

A Q&A with Bryan Laffitte, who leads a Novartis team that’s using the tools of genetic medicine to innovate new therapies for neuromuscular and neurodegenerative conditions.

Novartis is proud to share that TIME has recognized Victor Bultó and Thierry Diagana among the most influential people shaping the future of health. Learn more about what drives our honorees.

The creation of a 700,000-square-foot flagship manufacturing hub marks the continuation of our investment in the US, enabling us to more reliably reach patients across the country.